Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block C. BuslettaE. NovoM. Parola Editorial 23 July 2011 Pages: 299 - 305
MELD—good for many, not as good for others … at least for now Thomas Schiano Editorial 25 July 2012 Pages: 306 - 308
The BAFFling problem of B cell-activating factor in nonalcoholic fatty liver disease Puneet PuriArun J. Sanyal Editorial 19 February 2013 Pages: 309 - 312
Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation Sunil TanejaYogesh ChawlaRadha K. Dhiman Editorial 03 September 2011 Pages: 313 - 315
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management Chun-Jen LiuPei-Jer ChenJia-Horng Kao Review Article 14 June 2011 Pages: 316 - 326
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection Wai-Kay SetoMan-Fung YuenChing-Lung Lai Review Article 19 June 2011 Pages: 327 - 334
Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure Keiichi FujiwaraShin YasuiOsamu Yokosuka Review Article 28 September 2012 Pages: 335 - 346
Model for End-Stage Liver Disease and liver cirrhosis-related complications Luis Calzadilla BertotEduardo Vilar GomezLuis Blanco Perez Review Article 10 October 2012 Pages: 347 - 355
Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B Yong-Peng ChenJie PengJin-Lin Hou Review Article 17 May 2013 Pages: 356 - 368
Role of anticoagulant therapy in liver disease Elisabeth P. C. PlompenJeoffrey N. L. SchoutenHarry L. A. Janssen Review Article 26 March 2013 Pages: 369 - 376
The risk factors and diagnosis of cholangiocarcinoma Christopher A. WadsworthAdrian LimShahid A. Khan Review Article 10 November 2012 Pages: 377 - 393
The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies Liesbeth CeelenMarusya LieveldMathieu Vinken Review Article 14 February 2013 Pages: 394 - 399
Nonalcoholic fatty liver disease following liver transplantation Sanjaya Kumar SatapathySatheesh NairJason M. Vanatta Review Article 26 April 2013 Pages: 400 - 412
Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? Carmine FinelliGiovanni Tarantino Review Article 26 October 2012 Pages: 413 - 428
Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients Teerha PiratvisuthPatrick MarcellinZhi-Meng Lu Original Article 24 June 2011 Pages: 429 - 436
Current management and recommendations on hepatitis B therapy in HIV-coinfected patients Lionel PirothSophie MahyFor the GERMIVIC Study Group Original Article 15 July 2011 Pages: 437 - 442
Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype Wenpeng LiNadia WarnerPeter A. Revill Original Article 28 November 2012 Pages: 443 - 450
Are physicians following guidelines? A survey of Hepatitis B management strategies Keat Hong LeeMyat Oo AungSeng Gee Lim Original Article 06 October 2012 Pages: 451 - 459
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B Bingliang LinCalvin Q. PanZhiliang Gao Original Article 11 February 2013 Pages: 460 - 467
Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection Fei PeiKewei ShangJiangfeng You Original Article 07 February 2013 Pages: 468 - 476
Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion Chien-Hung ChenChuan-Mo LeeSheng-Nan Lu Original Article 21 June 2012 Pages: 477 - 488
Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion Shih-Cheng YangSheng-Nan LuChien-Hung Chen Original Article 22 June 2012 Pages: 489 - 499
Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries Bilal AhmedTooba AliSaeed Hamid Original Article 10 January 2013 Pages: 500 - 507
Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C Shunsuke SatoTakuya GendaTakafumi Ichida Original Article 02 April 2011 Pages: 508 - 515
Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C Said M. HashemiDavid van der PoortenJacob George Original Article 27 September 2012 Pages: 516 - 523
Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication Jian-Wu YuLi-Jie SunBing-Zhu Yan Original Article 23 January 2013 Pages: 524 - 532
IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection Ayman A. AbdoMohammed N. Al-AhdalAhmed Al-Qahtani Original Article Open access 08 February 2013 Pages: 533 - 538
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease Teruki MiyakeMasanori AbeMorikazu Onji Original Article 09 February 2012 Pages: 539 - 547
Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia Seok-Chin GohEvelyn Lai-Ming HoKhean-Lee Goh Original Article 23 March 2012 Pages: 548 - 554
High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease Megumi InoueJunya OribeHironobu Yoshimatsu Original Article 05 April 2012 Pages: 555 - 561
Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin Deepa RanaAjay DusejaSunil K. Arora Original Article 06 May 2012 Pages: 562 - 569
Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety Vincenzo GianturcoGiovanni TroisiVincenzo Marigliano Original Article 03 July 2012 Pages: 570 - 576
The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH) Eiji KakazuYasuteru KondoTooru Shimosegawa Original Article 14 August 2012 Pages: 577 - 585
Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components Seonah KimJaekyung ChoiMina Kim Original Article 29 November 2012 Pages: 586 - 591
The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients Meredith A. BormanFarah LadakRobert P. Myers Original Article 29 September 2012 Pages: 592 - 599
Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative Jason J. SchwartzLyska EmersonMary Rinella Original Article 19 February 2013 Pages: 600 - 609
Fatty liver score and 15-year incidence of type 2 diabetes Anna KotronenMaarit A. LaaksonenPaul Knekt Original Article 12 March 2013 Pages: 610 - 621
Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension Moattar Raza RizviMohammad TauseefShiv Kumar Sarin Original Article 02 September 2012 Pages: 622 - 635
Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding Xiangguo TianYongjun ShiChunqing Zhang Original Article 13 March 2013 Pages: 636 - 644
Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma Yun-Hsuan LeeChia-Yang HsuShou-Dong Lee Original Article 17 May 2012 Pages: 645 - 654
The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver Masaaki HidakaMitsuhisa TakatsukiSusumu Eguchi Original Article 24 June 2012 Pages: 655 - 661
Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy Ali MuhiTomoaki IchikawaTsutomu Araki Original Article 22 June 2012 Pages: 662 - 668
p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis Shuting JiaWenru TangYing Luo Original Article 03 August 2012 Pages: 669 - 675
Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma? Tsung-Hsing HungChen-Chi TsaiHan-Chieh Lin Original Article 27 July 2012 Pages: 676 - 682
SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV Kazuhiro HamaokaSumiko NagoshiSatoshi Mochida Original Article 06 October 2012 Pages: 683 - 692
Type 2 diabetes, smoking, insulin use, and mortality from hepatocellular carcinoma: a 12-year follow-up of a national cohort in Taiwan Chin-Hsiao Tseng Original Article 06 October 2012 Pages: 693 - 702
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma Sadahisa OgasawaraFumihiko KanaiOsamu Yokosuka Original Article 12 February 2013 Pages: 703 - 713
Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey Shaoli YouYihui RongShaojie Xin Original Article 07 February 2013 Pages: 714 - 720
Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats Benjamin Fredrick GruenbaumMatthew BoykoAlexander Zlotnik Original Article 22 November 2012 Pages: 721 - 727
Short- and long-term outcomes of third liver transplantation at single centre Hideya KameiMamoun Al-BasheerDouglas Quan Original Article 14 March 2012 Pages: 728 - 733